Rare
lephants
Screener
Toggle theme
ANI PHARMACEUTICALS, INC
ANIP
·
Healthcare, Drug Manufacturers - General, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
Total Cash from Operations:
$111.8M
Line Item
Value
% of Total
Capital Expenditures
$10.4M
9.3%
Other Investing
$97.6M
87.3%
Net Cash Flow
$3.8M
3.4%
Download CSV
